• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症生物标志物:未来的巨大希望。

Biomarker for Cancer: A great Promise for Future.

作者信息

Karley Dugeshwar, Gupta Deepesh, Tiwari Archana

机构信息

School of biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya Bhopal, M.P. India.

出版信息

World J Oncol. 2011 Aug;2(4):151-157. doi: 10.4021/wjon352w. Epub 2011 Aug 24.

DOI:10.4021/wjon352w
PMID:29147241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649652/
Abstract

Cancer is an uncontrolled growth of a cell due to failure in the cell growth signaling system. Cure of cancer is done only by the complete removal of cancerous cells from the body, the process may sound simple but its implementation is almost impossible. There are number of problems regarding its treatment such as its early detection. Science is progressing every second and so are our expectations. This review is about present scenario and future promises about the development of biomarkers. It is a big challenge whose completion will be beneficial in the early detection of cancer. As early detection is half victory in any disease, especially cancer, this kind of research will be advantageous in the field of cancer treatment.

摘要

癌症是由于细胞生长信号系统故障导致的细胞不受控制的生长。癌症的治愈只能通过从体内完全清除癌细胞来实现,这个过程听起来可能很简单,但实际上几乎不可能实现。关于癌症治疗存在许多问题,比如早期检测。科学每一秒都在进步,我们的期望也是如此。这篇综述是关于生物标志物发展的现状和未来前景。这是一个巨大的挑战,其完成将有利于癌症的早期检测。由于早期检测在任何疾病尤其是癌症中都是成功的一半,这种研究在癌症治疗领域将是有益的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0095/5649652/e27b96363a32/wjon-02-151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0095/5649652/e27b96363a32/wjon-02-151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0095/5649652/e27b96363a32/wjon-02-151-g001.jpg

相似文献

1
Biomarker for Cancer: A great Promise for Future.癌症生物标志物:未来的巨大希望。
World J Oncol. 2011 Aug;2(4):151-157. doi: 10.4021/wjon352w. Epub 2011 Aug 24.
2
Contribution of oncoproteomics to cancer biomarker discovery.肿瘤蛋白质组学在癌症生物标志物发现中的作用。
Mol Cancer. 2007 Apr 2;6:25. doi: 10.1186/1476-4598-6-25.
3
Oncoproteomics: Current status and future opportunities.癌蛋白质组学:现状与未来机遇。
Clin Chim Acta. 2019 Aug;495:611-624. doi: 10.1016/j.cca.2019.06.006. Epub 2019 Jun 6.
4
New cancer biomarkers deriving from NCI early detection research.源自美国国立癌症研究所早期检测研究的新型癌症生物标志物。
Recent Results Cancer Res. 2003;163:72-84; discussion 264-6. doi: 10.1007/978-3-642-55647-0_7.
5
Genotypic and phenotypic biomarker profiles for individual risk assessment and cancer detection (lessons from bladder cancer risk assessment in symptomatic patients and workers exposed to benzidine).用于个体风险评估和癌症检测的基因型和表型生物标志物谱(有症状患者和接触联苯胺工人膀胱癌风险评估的经验教训)
Front Biosci. 2004 Sep 1;9:2671-9. doi: 10.2741/1426.
6
Oncoproteomics: current trends and future perspectives.肿瘤蛋白质组学:当前趋势与未来展望。
Expert Rev Proteomics. 2007 Jun;4(3):401-10. doi: 10.1586/14789450.4.3.401.
7
Role of oncoproteomics in the personalized management of cancer.肿瘤蛋白质组学在癌症个性化管理中的作用。
Expert Rev Proteomics. 2004 Jun;1(1):49-55. doi: 10.1586/14789450.1.1.49.
8
Multi-biomarker panel signature as the key to diagnosis of ovarian cancer.多生物标志物组合特征作为卵巢癌诊断的关键
Heliyon. 2019 Dec 5;5(12):e02826. doi: 10.1016/j.heliyon.2019.e02826. eCollection 2019 Dec.
9
Oncoproteomics: Trials and tribulations.肿瘤蛋白质组学:试验与磨难
Proteomics Clin Appl. 2016 Apr;10(4):516-31. doi: 10.1002/prca.201500081. Epub 2015 Dec 9.
10
Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.使用低剂量胸部 CT 筛查早期肺癌、慢性阻塞性肺疾病和心血管疾病(Big-3):当前证据和技术考虑因素。
J Thorac Imaging. 2019 May;34(3):160-169. doi: 10.1097/RTI.0000000000000379.

引用本文的文献

1
Diagnostic and prognostic relevance of gene in acute myeloid leukemia.基因在急性髓系白血病中的诊断和预后相关性
Leuk Res Rep. 2025 Jul 10;24:100528. doi: 10.1016/j.lrr.2025.100528. eCollection 2025.
2
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.液体活检在儿科实体瘤中的应用综述
NPJ Precis Oncol. 2024 Aug 3;8(1):172. doi: 10.1038/s41698-024-00657-z.
3
Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases.

本文引用的文献

1
Molecular and clinical markers of pancreas cancer.胰腺癌的分子和临床标志物
JOP. 2010 Nov 9;11(6):536-44.
2
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
3
Challenges in cancer research and multifaceted approaches for cancer biomarker quest.癌症研究中的挑战以及寻找癌症生物标志物的多方面方法。
生物标志物作为生物医学指示物:疾病新型生物标志物的检测、分析及验证方法与技术
Pharmaceutics. 2023 May 31;15(6):1630. doi: 10.3390/pharmaceutics15061630.
4
Mass spectrometry imaging in gynecological cancers: the best is yet to come.妇科癌症中的质谱成像:更美好的未来尚待开启。
Cancer Cell Int. 2022 Dec 19;22(1):414. doi: 10.1186/s12935-022-02832-3.
5
Prognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis.CD90表达在癌症患者中的预后及临床病理价值:一项系统评价与荟萃分析
Transl Cancer Res. 2021 Jul;10(7):3356-3363. doi: 10.21037/tcr-21-266.
6
In situ growth of electroactive polymers via ATRP to construct a biosensing interface for tumor marker.通过原子转移自由基聚合(ATRP)原位生长电活性聚合物,构建用于肿瘤标志物的生物传感界面。
Mikrochim Acta. 2021 Oct 22;188(11):389. doi: 10.1007/s00604-021-05048-w.
7
The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers.阿尔茨海默病的另一面:代谢紊乱特征对新型诊断生物标志物的影响。
J Pers Med. 2020 Sep 6;10(3):115. doi: 10.3390/jpm10030115.
8
New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples.用于选择性检测人细胞系和生物样本中膜结合型和可溶性碳酸酐酶 IX 的新型单克隆抗体。
Biomolecules. 2019 Jul 25;9(8):304. doi: 10.3390/biom9080304.
9
Proteins are potent biomarkers to detect colon cancer progression.蛋白质是检测结肠癌进展的有效生物标志物。
Saudi J Biol Sci. 2017 Sep;24(6):1212-1221. doi: 10.1016/j.sjbs.2014.09.017. Epub 2014 Oct 5.
10
Electrochemistry-based approaches to low cost, high sensitivity, automated, multiplexed protein immunoassays for cancer diagnostics.基于电化学的方法用于癌症诊断的低成本、高灵敏度、自动化、多重蛋白质免疫分析。
Analyst. 2016 Jan 21;141(2):536-47. doi: 10.1039/c5an01829c. Epub 2015 Nov 3.
FEBS Lett. 2009 Jun 5;583(11):1772-84. doi: 10.1016/j.febslet.2009.03.042. Epub 2009 Mar 25.
4
Contribution of oncoproteomics to cancer biomarker discovery.肿瘤蛋白质组学在癌症生物标志物发现中的作用。
Mol Cancer. 2007 Apr 2;6:25. doi: 10.1186/1476-4598-6-25.
5
Identification of specific protein markers in microdissected hepatocellular carcinoma.在显微切割的肝细胞癌中鉴定特定蛋白质标志物
J Proteome Res. 2007 Jan;6(1):306-15. doi: 10.1021/pr060439b.
6
Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions.不同肿瘤疾病患者血清热稳定组分的二维电泳蛋白质组学研究
Biochemistry (Mosc). 2006 Apr;71(4):354-60. doi: 10.1134/s000629790604002x.
7
Biomarkers: potential uses and limitations.生物标志物:潜在用途与局限性
NeuroRx. 2004 Apr;1(2):182-8. doi: 10.1602/neurorx.1.2.182.
8
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population.碳水化合物抗原19-9作为无症状人群胰腺癌筛查试验的临床实用性。
J Gastroenterol Hepatol. 2004 Feb;19(2):182-6. doi: 10.1111/j.1440-1746.2004.03219.x.